---
schema_version: "secwatch.filing_event.v1"
accession: "0001071739-23-000024"
form_type: "8-K"
ticker: "CNC"
cik: "0001071739"
company_name: "CENTENE CORP"
filed_at: "2023-02-07T23:59:59+00:00"
generated_at: "2026-06-19T22:25:04.502711+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Centene Q4 adj EPS $0.86, full-year adj EPS $5.78; revenue $144.5B (+15% YoY); guidance raised

## Summary
- Q4 total revenues $35.6B (+9% YoY); full-year 2022 revenues $144.5B (+15% YoY).
- Q4 GAAP diluted EPS $(0.38) includes $528M in impairments; adjusted diluted EPS $0.86.
- Full-year 2022 adjusted diluted EPS $5.78 (+12% YoY); health benefits ratio 87.7%.
- Completed five divestitures (Magellan Rx, Magellan Specialty Health, Ribera Salud, Centurion, HealthSmart).
- 2023 premium/service revenue guidance raised $2B to $131.5B-$133.5B; adj EPS guidance unchanged $6.25-$6.40.

## SEC filing metadata
- accession: 0001071739-23-000024
- form_type: 8-K
- ticker: CNC
- cik: 0001071739
- company_name: CENTENE CORP
- filed_at: 2023-02-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1071739/000107173923000024/0001071739-23-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1071739/000107173923000024/cnc-20230207.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001071739-23-000024
- JSON: https://secwatch.observer/filing/0001071739-23-000024.json
- Plain text: https://secwatch.observer/filing/0001071739-23-000024.txt

## Key facts
- Earnings Releases
  CENTENE CORP reported year ended December 31, 2022 results: revenue $144,547, EPS $2.07. Guidance raised.
  - Period: year ended December 31, 2022
  - Revenue: $144,547
  - EPS: $2.07
  - Guidance: raised
  - Result: reported results
  source text: In summary, the 2022 fourth quarter and full year results were as follows: 2022 Results Q4 Full Year Total revenues (in millions) $ 35,561 $ 144,547 Premium and service revenues (in millions) $ 33,553 $ 135,479 Health benefits ratio 88.7 % 87.7 % SG&A expense ratio 9.5 % 8.6 % Adjusted SG&A expense ratio (1) 9.3 % 8.4 % GAAP diluted earnings (loss) per share $ (0.38) $ 2.07 Adjusted diluted EPS (1) $ 0.86 $ 5.78
  evidence_url: https://www.sec.gov/Archives/edgar/data/1071739/000107173923000024/0001071739-23-000024-index.htm
- Earnings Releases
  CENTENE CORP reported fourth quarter ended December 31, 2022 results: revenue $35,561, EPS $ (0.38). Guidance raised.
  - Period: fourth quarter ended December 31, 2022
  - Revenue: $35,561
  - EPS: $ (0.38)
  - Guidance: raised
  - Result: reported results
  source text: In summary, the 2022 fourth quarter and full year results were as follows: 2022 Results Q4 Full Year Total revenues (in millions) $ 35,561 $ 144,547 Premium and service revenues (in millions) $ 33,553 $ 135,479 Health benefits ratio 88.7 % 87.7 % SG&A expense ratio 9.5 % 8.6 % Adjusted SG&A expense ratio (1) 9.3 % 8.4 % GAAP diluted earnings (loss) per share $ (0.38) $ 2.07 Adjusted diluted EPS (1) $ 0.86 $ 5.78
  evidence_url: https://www.sec.gov/Archives/edgar/data/1071739/000107173923000024/0001071739-23-000024-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.